Kodiak Sciences KOD 深 沪
已收盘 02-06 16:00:00 美东时间
23.04
+2.030
+9.66%
华盛通- 最 高23.46
- 今 开21.60
- 成交量 74.85万股
- 最 低 21.24
- 昨 收 21.01
- 总市值 14.07亿
- 52周最高 31.18
- 市盈率 静 --
- 换手率 1.23%
- 52周最低 1.92
- 委 比 41.11%
- 总股本 6104.84万
- 历史最高 171.21
- 量 比 0.99
- 振 幅 10.57%
- 历史最低 1.37
- 每 手 1
- 风险率 8.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-22 20:13
HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $38
HC Wainwright & Co. analyst Matthew Caufield maintains Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price target from $26 to $38.
01-22 20:03
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies Jan 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cencora, Crocs and Teledyne Technologies, on Thursday. HIGHLIGHTS * Cencora COR.N : Jefferies raises to b
01-22 15:17
Catalyst Watch: Big bank earnings, major healthcare + retail conferences, Fedspeak flurry, CPI
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - January 1...
01-10 04:00
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
PALO ALTO, Calif., Jan. 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializ...
01-08 09:19
UBS Initiates Coverage On Kodiak Sciences with Buy Rating, Announces Price Target of $50
UBS analyst Michael Yee initiates coverage on Kodiak Sciences (NASDAQ:KOD) with a Buy rating and announces Price Target of $50.
01-08 04:21
2026美股生物科技板块怎么投资？杰富瑞：关注6大首选、7大潜力和5大并购目标
杰富瑞近日发布了关于 2026 年美股生物科技行业的展望报告，聚焦行业首选投资标的、被低估的潜力企业和潜在并购机会。
2025-12-25 15:40
Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on ...
2025-12-25 00:06
